Rhumbline Advisers Chembio Diagnostics, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.88 - $5.64 $51,454 - $100,764	-17,866 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$4.11 - $7.51 $6,793 - $12,414	1,653 Added 10.2%	17,866 $85,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $19,647 - $35,520	-5,990 Reduced 26.98%	16,213 $79,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $70,605 - $345,034	22,203 New	22,203 $72,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.